Retrospective Cohort Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2024; 12(22): 4890-4896
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4890
Effect of bivalirudin on myocardial microcirculation and adverse events after interventional therapy in older patients with acute coronary syndrome
Ya-Kun Du, Li-Jun Cui, Hong-Bo Gao
Ya-Kun Du, Li-Jun Cui, Hong-Bo Gao, Cardiovascular Department, Hanzhong People’s Hospital, Hanzhong 723000, Shaanxi Province, China
Author contributions: Du YK, Cui LJ, and Gao HB designed the research study; Du YK, Cui LJ, and Gao HB performed the primary literature review and data extraction; Du YK and Cui LJ analyzed the data and wrote the manuscript; Du YK, Cui LJ, and Gao HB were responsible for revising the manuscript for intellectual content; All authors have read and approved the final version.
Institutional review board statement: The study was reviewed and approved by the Institutional Review Board of Hanzhong People’s Hospital.
Informed consent statement: All study participants or their legal guardians provided written informed consent for personal and medical data collection before study enrolment.
Conflict-of-interest statement: The authors declare they have nothing to disclose.
Data sharing statement: No other data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Bo Gao, MMed, Attending Doctor, Cardiovascular Department, Hanzhong People’s Hospital, No. 251 North Tuanjie Street, Hantai District, Hanzhong 723000, Shaanxi Province, China. g816176939331@163.com
Received: April 10, 2024
Revised: May 6, 2024
Accepted: June 5, 2024
Published online: August 6, 2024
Processing time: 82 Days and 20.9 Hours
Core Tip

Core Tip: Effective anticoagulation management is essential for older patients with acute coronary syndrome, especially in those with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Bivalirudin may be an innovative drug for achieving this goal.